Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CDNA

Caredx Inc

Nov 28 • 02:34PM ET

9.73

Dollar change +0.11
Percentage change 1.20	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.68	Insider Own	4.55%	Shs Outstand	53.53M	Perf Week	0.57%
Market Cap	526.66M	Forward P/E	-	EPS next Y	-1.54	Insider Trans	-1.66%	Shs Float	51.64M	Perf Month	94.70%
Income	-90.52M	PEG	-	EPS next Q	-0.47	Inst Own	99.29%	Short Float / Ratio	7.53% / 4.03	Perf Quarter	6.05%
Sales	297.14M	P/S	1.77	EPS this Y	-28.61%	Inst Trans	-1.62%	Short Interest	3.89M	Perf Half Y	22.15%
Book/sh	7.28	P/B	1.34	EPS next Y	17.03%	ROA	-17.31%	Target Price	10.80	Perf Year	-23.89%
Cash/sh	4.96	P/C	1.96	EPS next 5Y	20.00%	ROE	-21.79%	52W Range	4.80 - 18.04	Perf YTD	-14.68%
Dividend	-	P/FCF	-	EPS past 5Y	9.60%	ROI	-21.38%	52W High	-46.04%	Beta	1.34
Dividend %	-	Quick Ratio	4.50	Sales past 5Y	47.69%	Gross Margin	63.57%	52W Low	102.81%	ATR	0.51
Employees	738	Current Ratio	4.75	Sales Q/Q	-15.33%	Oper. Margin	-33.32%	RSI (14)	75.51	Volatility	3.30% 7.01%
Optionable	Yes	Debt/Eq	0.09	EPS Q/Q	-36.88%	Profit Margin	-30.46%	Rel Volume	0.86	Prev Close	9.62
Shortable	Yes	LT Debt/Eq	0.07	Earnings	Nov 08 AMC	Payout	-	Avg Volume	964.13K	Price	9.73
Recom	2.29	SMA20	25.43%	SMA50	39.93%	SMA200	9.53%	Volume	654,473	Change	1.20%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-09-23	Upgrade	Stephens	Equal-Weight → Overweight	$10
Aug-15-23	Upgrade	Raymond James	Mkt Perform → Outperform	$12
May-11-23	Downgrade	BTIG Research	Buy → Neutral
Mar-07-23	Downgrade	Stephens	Overweight → Equal-Weight	$19 → $9
Mar-03-23	Downgrade	Raymond James	Strong Buy → Mkt Perform
Mar-03-23	Downgrade	Craig Hallum	Buy → Hold	$26 → $9
Apr-25-22	Initiated	Stephens	Overweight	$50
Jul-20-21	Resumed	BTIG Research	Buy	$115
Jun-03-21	Initiated	Goldman	Buy	$95
Feb-26-21	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-30-20	Reiterated	H.C. Wainwright	Buy	$47 → $55
Oct-08-20	Reiterated	H.C. Wainwright	Buy	$45 → $47
Oct-02-20	Reiterated	H.C. Wainwright	Buy	$40 → $45
Aug-05-20	Reiterated	H.C. Wainwright	Buy	$37 → $40
Jun-26-20	Initiated	BTIG Research	Buy	$40
Jun-19-20	Reiterated	H.C. Wainwright	Buy	$40 → $37
Oct-01-19	Resumed	Craig Hallum	Buy	$48
May-09-19	Upgrade	H.C. Wainwright	Neutral → Buy	$30 → $43
Feb-15-19	Initiated	Jefferies	Buy	$35
Oct-23-18	Resumed	Raymond James	Strong Buy	$30

Show Previous Ratings

Nov-22-23 09:55AM	Can CareDx (CDNA) Climb 29.79% to Reach the Level Wall Street Analysts Expect? (Zacks)
Nov-10-23 10:15AM	CareDx, Inc (NASDAQ:CDNA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 05:02PM	CareDx: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Reports Third Quarter 2023 Results (Business Wire)
Nov-06-23 07:38AM	CareDx (CDNA) Surges 16.6%: Is This an Indication of Further Gains? (Zacks)
04:05PM	Loading…
Nov-02-23 04:05PM	CareDx to Report Third Quarter 2023 Financial Results (Business Wire) +9.98%
Nov-01-23 04:02PM	CareDx Announces CEO Transition (Business Wire)
Oct-17-23 07:00AM	CareDx Presents New Data at the American Society for Histocompatibility and Immunogenetics Annual Meeting (Business Wire)
Oct-03-23 07:12PM	Market Today: Tech Stocks Under Pressure, House Ousts McCarthy, and FTC Accuses Amazon of Price ... (GuruFocus.com)
06:00PM	CareDx Issues Statement on Supreme Court Decision Regarding Stanford-Licensed Patents (Business Wire)
04:43PM	Supreme Court Denies CareDx Request for Appeal in Patent Case with Natera (Business Wire)
Oct-02-23 11:06AM	US Supreme Court rebuffs CareDx patent lawsuit over organ-rejection tests (Reuters)
Sep-19-23 07:00AM	CareDx To Present at the 2023 Cantor Global Healthcare Conference (Business Wire)
Sep-14-23 02:00AM	CareDx Advances Global Transplant Patient Care at ESOT Congress 2023 (Business Wire)
Aug-31-23 07:00AM	CareDx To Present at the H.C. Wainwright 25th Annual Global Investment Conference (Business Wire)
07:00AM	Loading…
Aug-17-23 07:00AM	CareDx Hosts Second Annual MEET Digital Health User Conference to Showcase Latest Innovations to Enhance Transplant Patient Care (Business Wire)
Aug-15-23 09:59AM	Redfin upgraded, CSSE downgraded: Wall Street's top analyst calls (The Fly)
Aug-11-23 07:00AM	CareDx Comments on Issuance of Proposed LCD for Molecular Testing for Solid Allograft Rejection (Business Wire) -8.06%
Aug-09-23 09:30AM	Compared to Estimates, CareDx (CDNA) Q2 Earnings: A Look at Key Metrics (Zacks) -11.23%
Aug-08-23 06:05PM	CareDx (CDNA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:02PM	CareDx: Q2 Earnings Snapshot (AP Finance)
04:05PM	CareDx Reports Second Quarter 2023 Results (Business Wire)
Aug-07-23 11:08AM	CareDx Announces District Court Judge Bars Natera from Falsely Advertising and Overstating the Scientific Performance of its Prospera Transplant Test (Business Wire)
Aug-03-23 07:00AM	CareDx to Report Second Quarter 2023 Financial Results (Business Wire)
Aug-02-23 07:00AM	CareDxs HeartCare Multimodality Service Receives Medicare Coverage for Heart Transplant Surveillance (Business Wire) +7.34%
Jul-25-23 07:00AM	CareDx Acquires MediGO, an Organ Transplant Supply Chain and Logistics Company (Business Wire) +5.76%
Jul-17-23 11:42PM	CareDx Applauds District Court Decision to Uphold Jury Verdict that Natera Falsely Advertised its Prospera Transplant Test (Business Wire)
Jul-11-23 07:00AM	CareDxs AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage for Lung Transplant Rejection Monitoring (Business Wire) +6.49%
Jul-10-23 08:44AM	CareDx (CDNA) Soars 20.6%: Is Further Upside Left in the Stock? (Zacks)
Jul-07-23 12:26PM	Why Shares of CareDx Are Jumping Friday (Motley Fool) +20.55%
06:08AM	Loading…
Jul-05-23 06:08AM	We're Hopeful That CareDx (NASDAQ:CDNA) Will Use Its Cash Wisely (Simply Wall St.)
Jun-01-23 08:00AM	CareDx Demonstrates Innovation Leadership at 2023 Transplant Congress (Business Wire)
07:00AM	CareDx to Participate in Upcoming Investor Conferences (Business Wire)
May-16-23 07:00AM	CareDx Showcases Digital Health Portfolio at 31st Annual UNOS Transplant Management Forum (Business Wire) -6.83%
06:42AM	Should You Exit CareDx (CDNA)? (Insider Monkey)
06:02AM	What Does The Future Hold For CareDx, Inc (NASDAQ:CDNA)? These Analysts Have Been Cutting Their Estimates (Simply Wall St.)
May-11-23 10:13AM	Q1 2023 CareDx Inc Earnings Call (Thomson Reuters StreetEvents)
May-10-23 05:45PM	CareDx (CDNA) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:43PM	CareDx: Q1 Earnings Snapshot (AP Finance)
04:05PM	CareDx Reports First Quarter 2023 Results (Business Wire)
May-08-23 07:01AM	CareDx to Report First Quarter 2023 Financial Results (Business Wire)
Apr-25-23 06:01AM	CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference (Business Wire) -5.21%
Apr-19-23 07:01AM	CareDx Showcases Leadership with Over 55 Oral Presentations and Posters at the 43rd Annual Meeting & Scientific Sessions of the International Society for Heart and Lung Transplantation (Business Wire)
Apr-18-23 01:22PM	CareDx, Inc's (NASDAQ:CDNA) Shares Lagging The Industry But So Is The Business (Simply Wall St.)
Apr-06-23 07:01AM	National Kidney Foundation Honors CareDx with Corporate Citizenship Award for its Commitment to the Transplant Community (Business Wire)
Apr-05-23 06:55AM	CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation (Business Wire)
Mar-23-23 07:01AM	CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association (Business Wire)
Mar-11-23 02:46AM	CareDx, Inc (NASDAQ:CDNA) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 07:01AM	The American Society of Transplant Surgeons Position Statement Supports Use of CareDxs AlloSure Kidney for Organ Transplant Surveillance (Business Wire)
Mar-06-23 04:32PM	CareDx Update Regarding Raymond James & Associates Conference (Business Wire) +18.73%
07:01AM	CareDx To Participate in the Raymond James & Associates 44th Annual Institutional Investors Conference (Business Wire)
Mar-03-23 04:01PM	CareDx Earns Stock Downgrade Amid CMS Coverage Cuts Change Thesis (Benzinga) -16.67%
07:01AM	CareDx Comments on MolDX Publication of New Billing and Coding Article (Business Wire)
Mar-01-23 07:01AM	CareDx Key Supporter of the National Kidney Foundations Annual Kidney Patient Summit (Business Wire)
05:19AM	CareDx Full Year 2022 Earnings: In Line With Expectations (Simply Wall St.)
Feb-28-23 09:58AM	Q4 2022 CareDx Inc Earnings Call (Thomson Reuters StreetEvents) +14.34%
Feb-27-23 05:15PM	CareDx (CDNA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:01PM	CareDx Reports Fourth Quarter and Full Year 2022 Results (Business Wire)
06:28AM	Baron Discovery Fund Believes CareDx (CDNA) Will Reward Investors for Patience (Insider Monkey)
Feb-22-23 07:01AM	CareDx Showcases Clinical Value of Multimodality and AI Innovation at the American Society of Transplantation Cutting Edge of Transplantation Meeting (Business Wire)
Feb-21-23 04:01PM	CareDx to Report Fourth Quarter and Full Year 2022 Financial Results (Business Wire) -13.72%
Feb-20-23 10:00AM	Analysts Estimate Viatris (VTRS) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-16-23 10:01AM	Earnings Preview: CareDx (CDNA) Q4 Earnings Expected to Decline (Zacks)
07:01AM	CareDx Showcases Latest Advancements in Cellular Transplant and Therapy Including Specialized Digital Health Solutions at the 2023 Tandem Meetings (Business Wire)
Feb-01-23 09:48AM	Cathie Wood pours millions into these 2 stocks this is what makes them attractive buys (TipRanks)
Jan-27-23 08:30AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jan-26-23 08:21AM	CareDx (NASDAQ:CDNA) delivers shareholders splendid 20% CAGR over 5 years, surging 9.8% in the last week alone (Simply Wall St.)
07:01AM	JACC Publication Guides Use of CareDxs HeartCare Transplant Rejection Surveillance in Clinical Practice (Business Wire)
Jan-11-23 07:01AM	CareDx Fosters Transplant Innovation as Distinguished Founders Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium (Business Wire) +8.23%
Jan-09-23 07:00AM	CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022 (Business Wire) +5.60%
Dec-21-22 06:00PM	New ISHLT Guidelines Support Use of CareDxs HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients (Business Wire)
Dec-14-22 07:00AM	Voyager Therapeutics Appoints Grace E. Colón, Ph.D., to its Board of Directors (GlobeNewswire)
Dec-06-22 08:01AM	CareDx Announces $50 Million Stock Repurchase Program (Business Wire) +5.27%
Dec-05-22 03:49PM	13 Best Genomics Stocks To Buy Now (Insider Monkey) -5.22%
Dec-01-22 08:15AM	Independent Prospective Study Defines Reference Range for CareDxs AlloSure for Long-Term Lung Transplant Surveillance (Business Wire)
Nov-17-22 09:55AM	Here's Why CareDx (CDNA) Could be Great Choice for a Bottom Fisher (Zacks) +6.74%
Nov-11-22 09:35AM	CareDx (CDNA) Loses 22.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) +17.10%
07:01AM	CareDx Committed to Delivering Clinical Innovation to the Transplant Patient and Physician Community (Business Wire)
Nov-06-22 07:34AM	Analysts Have Been Trimming Their CareDx, Inc (NASDAQ:CDNA) Price Target After Its Latest Report (Simply Wall St.)
Nov-04-22 07:00AM	CareDx To Participate in Upcoming Investor Conferences (Business Wire) -14.47%
Nov-03-22 06:15PM	CareDx (CDNA) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:01PM	CareDx Reports Third Quarter 2022 Results (Business Wire)
Nov-02-22 07:01AM	CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week (Business Wire)
Nov-01-22 12:19PM	Do You Think CareDx (CDNA) Has Huge Growth Potential? (Insider Monkey)
07:01AM	Independent Longitudinal Study Finds CareDxs AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients (Business Wire)
Oct-27-22 07:01AM	CareDx Congratulates C-Path's Transplant Therapeutics Consortium and Paris Transplant Group for Receiving EMA Draft Qualification for iBox Scoring System (Business Wire)
Oct-26-22 07:30AM	CareDx to Report Third Quarter 2022 Financial Results (Business Wire) +6.67%
07:01AM	CareDx Joins Forces with National Kidney Foundation and Honor the Gift Coalition to Host Immuno Bill Webinar for Kidney Transplant Patients (Business Wire)
Oct-25-22 07:01AM	CareDx Presents Latest Data on AlloSeq NGS Solutions and Transplant Innovation at the American Society for Histocompatibility and Immunogenetics Annual Meeting (Business Wire) +6.71%
Oct-20-22 06:00AM	Dont Put CareDX Stock in Your Portfolios Pipeline (InvestorPlace) +7.19%
Sep-29-22 07:01AM	CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care (Business Wire)
Sep-27-22 07:01AM	Transplant Patients Experience Less Pain and Fewer Adverse Events with CareDx Non-Invasive Testing Solutions (Business Wire)
Sep-26-22 08:43AM	CareDx Congratulates Board Member Dr. Grace Colón for Being Named Healthcare Innovator on Top 50 Most Powerful Latinas List (Business Wire)
Sep-19-22 07:01AM	CareDx Showcases Transplant Digital Leadership in Patient Care at 2022 MEET Conference (Business Wire)
Sep-14-22 07:01AM	CareDx Celebrates 1 Million Organ Transplants and 100,000 Patient Milestone (Business Wire)
Sep-13-22 09:08AM	Icon PLC (ICLR) Surges 3%: Is This an Indication of Further Gains? (Zacks) -5.57%
Sep-12-22 07:01AM	CareDx Demonstrates Global Leadership at 29th International Congress of The Transplantation Society (Business Wire)
Aug-30-22 06:41AM	Cathie Wood Goes Bargain-Shopping: 3 Stocks She Just Bought (Motley Fool)
Aug-18-22 06:51AM	CareDx (NASDAQ:CDNA) pulls back 14% this week, but still delivers shareholders incredible 59% CAGR over 5 years (Simply Wall St.)
Aug-11-22 07:01AM	CareDx and MOTTEP Co-Host Health Equity Summit (Business Wire) -8.40%

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Seeto Reginald	See Remarks	Oct 02	Sale	6.91	2,818	19,483	479,164	Oct 02 07:53 PM
Seeto Reginald	See Remarks	Sep 05	Sale	9.49	2,819	26,762	481,982	Sep 05 04:03 PM
Seeto Reginald	See Remarks	Aug 14	Sale	8.89	576	5,123	484,801	Aug 14 07:52 PM
Bickerstaff George	Director	Aug 11	Option Exercise	5.09	19,453	99,065	99,721	Aug 11 07:47 PM
Seeto Reginald	See Remarks	Aug 02	Sale	11.35	2,819	31,988	486,051	Aug 02 06:53 PM
Seeto Reginald	See Remarks	Jul 13	Sale	10.33	5,260	54,357	488,870	Jul 13 08:56 PM
Maag Peter	Director	Jul 13	Sale	10.34	5,000	51,680	309,657	Jul 13 08:56 PM
Seeto Reginald	See Remarks	Jul 03	Sale	8.48	2,818	23,901	498,055	Jul 03 05:19 PM
Seeto Reginald	See Remarks	Jun 28	Sale	8.76	14,268	125,016	500,873	Jun 28 08:44 PM
Maag Peter	Director	Jun 28	Sale	8.72	2,432	21,216	313,136	Jun 28 08:43 PM
Seeto Reginald	See Remarks	Jun 02	Sale	8.13	2,819	22,911	532,177	Jun 02 08:08 PM
Seeto Reginald	See Remarks	May 02	Sale	8.12	2,819	22,898	534,996	May 04 05:36 PM
Seeto Reginald	See Remarks	Apr 03	Sale	8.95	2,818	25,225	537,815	Apr 03 08:38 PM
Seeto Reginald	See Remarks	Mar 02	Sale	15.88	2,819	44,758	540,633	Mar 06 06:01 PM
Seeto Reginald	See Remarks	Feb 10	Sale	15.48	8,488	131,386	543,452	Feb 13 06:02 PM
Seeto Reginald	See Remarks	Feb 09	Sale	16.13	11,094	178,928	551,940	Feb 13 06:02 PM
Maag Peter	Director	Feb 08	Sale	15.75	3,269	51,501	295,468	Feb 08 05:51 PM
Seeto Reginald	See Remarks	Feb 07	Sale	16.40	3,069	50,337	563,034	Feb 08 05:51 PM
Maag Peter	Director	Feb 02	Sale	17.17	5,000	85,830	298,737	Feb 03 09:46 PM
Seeto Reginald	See Remarks	Feb 02	Sale	17.15	2,819	48,347	575,803	Feb 03 09:47 PM
Seeto Reginald	See Remarks	Jan 03	Sale	11.69	2,818	32,936	268,906	Jan 03 05:10 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CDNA

Caredx Inc

Upgrade your FINVIZ experience